• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

没食子酸丙酯通过下调 c-Fos 和 NFATc1 抑制破骨细胞分化。

Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1.

机构信息

Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Korea.

Department of Food Science and Biotechnology, Daegu University, Gyeongsan 38453, Korea.

出版信息

Int J Mol Sci. 2018 Feb 17;19(2):601. doi: 10.3390/ijms19020601.

DOI:10.3390/ijms19020601
PMID:29463002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5855823/
Abstract

Purpurogallin, a benzotropolone-containing natural compound, has been reported to exhibit numerous biological and pharmacological functions, such as antioxidant, anticancer, and anti-inflammatory effects. In this study, we enzymatically synthesized purpurogallin from pyrogallol and investigated its role in receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis. Purpurogallin attenuated the formation of multinucleated tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts from bone marrow macrophages (BMMs) without causing cytotoxicity, and suppressed upregulation of osteoclast-specific markers, including TRAP (Acp5), cathepsin K (Ctsk), and dendritic cell-specific transmembrane protein (Dcstamp). However, purpurogallin did not affect the bone resorbing function of mature osteoclasts evident by the resorption pit assay. Activation of mitogen-activated protein kinases, Akt and IkB pathways in RANK signaling were not altered by purpurogallin, whereas the expression of c-Fos and NFATc1, key transcriptional regulators in osteoclastogenesis, was dramatically inhibited by purpurogallin. Purpurogallin also significantly reduced the expression level of B lymphocyte-induced maturation protein-1 (Blimp1) gene (Prdm1). Further, downregulation of Blimp1 led to forced expression of anti-osteoclastogenic genes, including interferon regulatory factor-8 (Irf8) and B-cell lymphoma 6 (Bcl6) genes. Taken together, our data suggested that purpurogallin inhibits osteoclast differentiation via downregulation of c-Fos and NFATc1.

摘要

没食子酸丙酯,一种含苯并三唑酮的天然化合物,据报道具有多种生物学和药理学功能,如抗氧化、抗癌和抗炎作用。在本研究中,我们从焦儿茶酚酶促合成了没食子酸丙酯,并研究了其在核因子-κB 受体激活剂配体(RANKL)诱导的破骨细胞分化中的作用。没食子酸丙酯抑制了骨髓巨噬细胞(BMM)中多核抗酒石酸酸性磷酸酶(TRAP)阳性破骨细胞的形成,而没有引起细胞毒性,并抑制了破骨细胞特异性标志物的上调,包括 TRAP(Acp5)、组织蛋白酶 K(Ctsk)和树突状细胞特异性跨膜蛋白(Dcstamp)。然而,没食子酸丙酯并没有影响成熟破骨细胞的骨吸收功能,这可以通过吸收陷窝试验证明。RANK 信号转导中丝裂原活化蛋白激酶(Akt 和 IkB 途径)的激活不受没食子酸丙酯的影响,而破骨细胞分化中的关键转录调节因子 c-Fos 和 NFATc1 的表达则被没食子酸丙酯显著抑制。没食子酸丙酯还显著降低了 B 淋巴细胞诱导成熟蛋白-1(Blimp1)基因(Prdm1)的表达水平。此外,下调 Blimp1 导致抗破骨细胞基因,包括干扰素调节因子-8(Irf8)和 B 细胞淋巴瘤 6(Bcl6)基因的强制表达。总之,我们的数据表明,没食子酸丙酯通过下调 c-Fos 和 NFATc1 抑制破骨细胞分化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/5f7cfb860faf/ijms-19-00601-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/c4931ecd128d/ijms-19-00601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/7a82736ab9c6/ijms-19-00601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/8672e93deca1/ijms-19-00601-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/57a7f1105f0a/ijms-19-00601-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/5f7cfb860faf/ijms-19-00601-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/c4931ecd128d/ijms-19-00601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/7a82736ab9c6/ijms-19-00601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/8672e93deca1/ijms-19-00601-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/57a7f1105f0a/ijms-19-00601-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf91/5855823/5f7cfb860faf/ijms-19-00601-g005.jpg

相似文献

1
Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1.没食子酸丙酯通过下调 c-Fos 和 NFATc1 抑制破骨细胞分化。
Int J Mol Sci. 2018 Feb 17;19(2):601. doi: 10.3390/ijms19020601.
2
Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice.Agrimophol 通过 Blimp1-Bcl6 轴抑制 RANKL 介导的破骨细胞生成,防止小鼠炎症性骨丢失。
Int Immunopharmacol. 2021 Jan;90:107137. doi: 10.1016/j.intimp.2020.107137. Epub 2020 Nov 14.
3
Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).成釉蛋白通过抑制活化 T 细胞核因子 1(NFATc1)的激活来减轻 RANKL 介导的破骨细胞生成。
J Cell Physiol. 2019 Feb;234(2):1745-1757. doi: 10.1002/jcp.27045. Epub 2018 Aug 13.
4
Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.柯诺菲林通过下调CREB抑制核因子κB受体激活剂配体或脂多糖诱导的破骨细胞形成。
Immunol Lett. 2014 Sep;161(1):31-7. doi: 10.1016/j.imlet.2014.04.006. Epub 2014 May 2.
5
Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.卡利卡丁酮可减少破骨细胞的形成和吸收,并防止炎症性骨丢失。
Int J Mol Sci. 2021 Feb 25;22(5):2303. doi: 10.3390/ijms22052303.
6
The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.甘草查尔酮 A 对 RANKL 诱导的 RAW264.7 细胞破骨细胞生成的抑制作用及分子机制。
Int J Mol Med. 2012 Feb;29(2):169-77. doi: 10.3892/ijmm.2011.822. Epub 2011 Oct 31.
7
Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption.卡瓦胡椒素对破骨细胞生成和骨吸收的抑制作用源于其对钙介导的 NFATc1 和丝裂原活化蛋白激酶失活的调节。
J Cell Physiol. 2018 Jan;234(1):789-801. doi: 10.1002/jcp.26893. Epub 2018 Aug 4.
8
The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.Blimp1-Bcl6 轴对于调节破骨细胞分化和骨稳态至关重要。
J Exp Med. 2010 Apr 12;207(4):751-62. doi: 10.1084/jem.20091957. Epub 2010 Apr 5.
9
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.曲匹地尔,一种血小板衍生生长因子拮抗剂,通过下调 NFATc1 抑制破骨细胞生成,并抑制小鼠的骨丢失。
Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6.
10
Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.人参皂苷Rb2通过核因子-κB和信号转导及转录激活蛋白3信号通路抑制破骨细胞分化。
Biomed Pharmacother. 2017 Aug;92:927-934. doi: 10.1016/j.biopha.2017.05.115. Epub 2017 Jun 8.

引用本文的文献

1
Morphological and environmental analysis of the glacier ice alga Ancylonema alaskanum.阿拉斯加锚丝藻的冰川冰藻形态与环境分析
Sci Rep. 2025 May 27;15(1):18578. doi: 10.1038/s41598-025-95754-9.
2
Irisin in the modulation of bone and cartilage homeostasis: a review on osteoarthritis relief potential.鸢尾素对骨骼和软骨稳态的调节作用:关于骨关节炎缓解潜力的综述
Front Physiol. 2025 Apr 17;16:1570157. doi: 10.3389/fphys.2025.1570157. eCollection 2025.
3
Denosumab ameliorates osteoarthritis by protecting cartilage against degradation and modulating subchondral bone remodeling.

本文引用的文献

1
Diphlorethohydroxycarmalol from Ishige okamurae Suppresses Osteoclast Differentiation by Downregulating the NF-κB Signaling Pathway.来自石莼 okamurae 的二氢愈创木酸通过下调 NF-κB 信号通路抑制破骨细胞分化。
Int J Mol Sci. 2017 Dec 6;18(12):2635. doi: 10.3390/ijms18122635.
2
Conversion to purpurogallin, a key step in the mechanism of the potent xanthine oxidase inhibitory activity of pyrogallol.转化为紫倍半萜酸,这是焦性没食子酸强大的黄嘌呤氧化酶抑制活性机制中的关键一步。
Free Radic Biol Med. 2017 May;106:228-235. doi: 10.1016/j.freeradbiomed.2017.02.037. Epub 2017 Feb 20.
3
OCLI-023, a Novel Pyrimidine Compound, Suppresses Osteoclastogenesis In Vitro and Alveolar Bone Resorption In Vivo.
地诺单抗通过保护软骨免受降解和调节软骨下骨重塑来改善骨关节炎。
Regen Ther. 2024 Mar 26;27:181-190. doi: 10.1016/j.reth.2024.03.019. eCollection 2024 Dec.
4
Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis.调控巨噬细胞/破骨细胞在减轻磨屑颗粒诱导的无菌性骨溶解中的作用机制。
Front Immunol. 2023 Oct 4;14:1274679. doi: 10.3389/fimmu.2023.1274679. eCollection 2023.
5
N-Butanol Extract of Modified You-Gui-Yin Attenuates Osteoclastogenesis and Ameliorates Osteoporosis by Inhibiting RANKL-Mediated NF-κB Signaling.加味右归饮正丁醇提取物通过抑制 RANKL 介导的 NF-κB 信号通路抑制破骨细胞分化,改善骨质疏松症。
Front Endocrinol (Lausanne). 2022 Jun 24;13:925848. doi: 10.3389/fendo.2022.925848. eCollection 2022.
6
A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways.一种新型 BRD4 抑制剂通过阻断 RANKL 介导的 MAPK 和 NF-κB 通路抑制破骨细胞生成和卵巢切除诱导的骨质疏松症。
Cell Death Dis. 2021 Jun 26;12(7):654. doi: 10.1038/s41419-021-03939-7.
7
Purpurogallin Protects Keratinocytes from Damage and Apoptosis Induced by Ultraviolet B Radiation and Particulate Matter 2.5.紫没食子素可保护角质形成细胞免受紫外线B辐射和细颗粒物2.5诱导的损伤和凋亡。
Biomol Ther (Seoul). 2019 Jul 1;27(4):395-403. doi: 10.4062/biomolther.2018.151.
8
Tanshinone IIA attenuates osteoclastogenesis in ovariectomized mice by inactivating NF-kB and Akt signaling pathways.丹参酮IIA通过使NF-κB和Akt信号通路失活来减轻去卵巢小鼠的破骨细胞生成。
Am J Transl Res. 2018 May 15;10(5):1457-1468. eCollection 2018.
新型嘧啶化合物OCLI-023在体外抑制破骨细胞生成,在体内抑制牙槽骨吸收。
PLoS One. 2017 Jan 13;12(1):e0170159. doi: 10.1371/journal.pone.0170159. eCollection 2017.
4
Purpurogallin exerts anti‑inflammatory effects in lipopolysaccharide‑stimulated BV2 microglial cells through the inactivation of the NF‑κB and MAPK signaling pathways.没食子酸丙酯通过抑制 NF-κB 和 MAPK 信号通路发挥抗炎作用。
Int J Mol Med. 2013 Nov;32(5):1171-8. doi: 10.3892/ijmm.2013.1478. Epub 2013 Aug 30.
5
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.双膦酸盐治疗骨质疏松症:获益、风险和药物假期。
Am J Med. 2013 Jan;126(1):13-20. doi: 10.1016/j.amjmed.2012.06.023. Epub 2012 Nov 20.
6
Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling.CD11b 和 β2 整合素-β-细胞淋巴瘤 6 信号通路对破骨细胞前体细胞分化的负调控。
J Bone Miner Res. 2013 Jan;28(1):135-49. doi: 10.1002/jbmr.1739.
7
The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.Blimp1-Bcl6 轴对于调节破骨细胞分化和骨稳态至关重要。
J Exp Med. 2010 Apr 12;207(4):751-62. doi: 10.1084/jem.20091957. Epub 2010 Apr 5.
8
Blimp1-mediated repression of negative regulators is required for osteoclast differentiation.Blimp1 介导的负调控因子抑制对于破骨细胞分化是必需的。
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3117-22. doi: 10.1073/pnas.0912779107. Epub 2010 Jan 28.
9
Bisphosphonate-associated adverse events.双膦酸盐相关不良事件。
Hormones (Athens). 2009 Apr-Jun;8(2):96-110. doi: 10.14310/horm.2002.1226.
10
Osteoporosis treatments and adverse events.骨质疏松症的治疗与不良事件。
Curr Opin Rheumatol. 2009 Jul;21(4):363-8. doi: 10.1097/BOR.0b013e32832ca433.